共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R028681-25mg | 25mg | 5~7个工作日 |
N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2... PD0325901 |
99% |
|
|
罗恩 | R028681-5mg | 5mg | 5~7个工作日 |
N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2... PD0325901 |
99% |
|
|
罗恩 | R028681-100mg | 100mg | 5~7个工作日 |
N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2... PD0325901 |
99% |
|
|
阿拉丁 | P125494-5mg | 5mg | 现货 |
PD0325901,MEK1 / 2的抑制剂 PD0325901 |
Moligand™, ≥99% |
|
|
阿拉丁 | P125494-25mg | 25mg | 现货 |
PD0325901,MEK1 / 2的抑制剂 PD0325901 |
Moligand™, ≥99% |
|
|
阿拉丁 | P125494-100mg | 100mg | 现货 |
PD0325901,MEK1 / 2的抑制剂 PD0325901 |
Moligand™, ≥99% |
|
|
阿拉丁 | M409191-1ml | 1ml | 期货,请咨询 |
Mirdametinib (PD0325901) Mirdametinib (PD0325901) |
Moligand™, 10mM in DMSO |
|
|
阿拉丁 | P125494-1mg | 1mg | 现货 |
PD0325901,MEK1 / 2的抑制剂 PD0325901 |
Moligand™, ≥99% |
|
|
凯为 | JZ0038IJ-5mg | 5mg | 期货,请咨询 |
N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2... N-[(2R)-2,3-Dihydroxypropoxy... |
98% |
|
|
凯为 | JZ0038IJ-100mg | 100mg | 期货,请咨询 |
N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2... N-[(2R)-2,3-Dihydroxypropoxy... |
98% |
|
|
凯为 | JZ0038IJ-250mg | 250mg | 期货,请咨询 |
N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2... N-[(2R)-2,3-Dihydroxypropoxy... |
98% |
|
|
凯为 | JZ0038IJ-1g | 1g | 期货,请咨询 |
N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2... N-[(2R)-2,3-Dihydroxypropoxy... |
98% |
|
|
凯为 | JZ0038IJ-5g | 5g | 期货,请咨询 |
N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2... N-[(2R)-2,3-Dihydroxypropoxy... |
98% |
|
|
毕得 | BD222618-5mg | 5mg | 现货 |
N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2... (R)-N-(2,3-Dihydroxypropoxy)... |
98% |
|
|
毕得 | BD222618-100mg | 100mg | 现货 |
N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2... (R)-N-(2,3-Dihydroxypropoxy)... |
98% |
|
|
毕得 | BD222618-250mg | 250mg | 现货 |
N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2... (R)-N-(2,3-Dihydroxypropoxy)... |
98% |
|
|
毕得 | BD222618-1g | 1g | 现货 |
N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2... (R)-N-(2,3-Dihydroxypropoxy)... |
98% |
|
|
毕得 | BD222618-5g | 5g | 现货 |
N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2... (R)-N-(2,3-Dihydroxypropoxy)... |
98% |
|
|
梯希爱 | P2897-10MG | 10MG | 现货 |
(R)-N-(2,3-二羟基丙氧基)-3,4-二氟-2-... PD 0325901 |
97.0% |
|
|
百灵威 | JK837005-10MG | 10MG | 1天 |
PD0325901抑制剂 PD0325901, 98%, a selective ... |
98% |
|
|
百灵威 | JK837005-25MG | 25MG | 1天 |
PD0325901抑制剂 PD0325901, 98%, a selective ... |
98% |
|
|
百灵威 | JK837005-100MG | 100MG | 35天 |
PD0325901抑制剂 PD0325901, 98%, a selective ... |
98% |
|
|
Matrix | MA057665-100mg | 100mg | 3-4周 |
(R)-N-(2,3-Dihydroxypropoxy)... (R)-N-(2,3-Dihydroxypropoxy)... |
95% | 咨询 | 请联系客服购买! |
Sigma | PZ0162-5MG | 5mg | 请咨询 |
PD 0325901 PD 0325901 |
≥98% (hplc)≥98% (HPLC) | 咨询 | 请联系客服购买! |
Sigma | PZ0162-25MG | 25mg | 请咨询 |
PD 0325901 PD 0325901 |
≥98% (hplc)≥98% (HPLC) | 咨询 | 请联系客服购买! |
源叶 | S46746-5mg | 5mg | 现货 |
PD0325901 PD0325901 |
≥99% |
|
|
源叶 | S46746-25mg | 25mg | 现货 |
PD0325901 PD0325901 |
≥99% |
|
|
源叶 | S46746-100mg | 100mg | 现货 |
PD0325901 PD0325901 |
≥99% |
|
|
源叶 | T98213-1ml | 1ml | 期货,请咨询 |
Mirdametinib (PD0325901) Mirdametinib (PD0325901) |
10mM in DMSO |
|
|
Target Mol | T6189-1mg | 1mg | 现货 |
化合物 PD0325901 Mirdametini |
99.63% |
|
|
Target Mol | T6189-5mg | 5mg | 现货 |
化合物 PD0325901 Mirdametini |
99.63% |
|
|
Target Mol | T6189-10mg | 10mg | 现货 |
化合物 PD0325901 Mirdametini |
99.63% |
|
|
Target Mol | T6189-25mg | 25mg | 现货 |
化合物 PD0325901 Mirdametini |
99.63% |
|
|
Target Mol | T6189-50mg | 50mg | 现货 |
化合物 PD0325901 Mirdametini |
99.63% |
|
|
Target Mol | T6189-100mg | 100mg | 现货 |
化合物 PD0325901 Mirdametini |
99.63% |
|
|
Target Mol | T6189-200mg | 200mg | 现货 |
化合物 PD0325901 Mirdametini |
99.63% |
|
|
Target Mol | T6189-1mL | 1mL | 现货 |
化合物 PD0325901 Mirdametini |
99.63% |
|
|
Target Mol | T6189-1g | 1g | 期货,请咨询 |
化合物 PD0325901 Mirdametini |
99.63% |
|
|
Am | A370482-5mg | 5mg | 现货 |
Mirdametinib Mirdametini |
98% |
|
|
Am | A370482-50mg | 50mg | 现货 |
Mirdametinib Mirdametini |
98% |
|
|
Am | A370482-10mg | 10mg | 现货 |
Mirdametinib Mirdametini |
98% |
|
|
Am | A370482-100mg | 100mg | 现货 |
Mirdametinib Mirdametini |
98% |
|
|
Am | A370482-25mg | 25mg | 现货 |
Mirdametinib Mirdametini |
98% |
|
|
MCE | HY-10254-100mg | 100mg | 现货 |
Mirdametinib Mirdametini |
99.95% |
|
|
MCE | HY-10254-50mg | 50mg | 现货 |
Mirdametinib Mirdametini |
99.95% |
|
|
MCE | HY-10254-25mg | 25mg | 现货 |
Mirdametinib Mirdametini |
99.95% |
|
|
MCE | HY-10254-10mg | 10mg | 现货 |
Mirdametinib Mirdametini |
99.95% |
|
|
MCE | HY-10254-10mM*1mL | 10mM*1mL | 现货 |
Mirdametinib Mirdametini |
99.95% |
|
|
MCE | HY-10254-5mg | 5mg | 现货 |
Mirdametinib Mirdametini |
99.95% |
|
|